Abstracts

HIV-1 INCIDENCE, PrEP UPTAKE, AND ADHERENCE AMONG KENYAN MSM

Data on HIV-1 incidence following programmatic pre-exposure prophylaxis (PrEP) uptake by men who have sex with men (MSM) in sub-Saharan Africa is not available. We assessed PrEP uptake and adherence, and HIV-1 incidence, in at-risk MSM with access to PrEP in coastal Kenya. Since June 2017, at-risk MSM followed at monthly visits were offered daily…

FACTORS ASSOCIATED WITH PrEP PERSISTENCE AND ADHERENCE AMONG MSM IN 4 US CITIES

Pre-exposure prophylaxis (PrEP) persistence and adherence are critical to achieving national HIV prevention goals. While there is no gold standard for measuring PrEP persistence (continued use) and adherence (effective use), biological testing for tenofovir diphosphate (TFV-DP) and emtricitabine (FTC) is considered best practice. We conducted testing for PrEP among HIV-negative men who have sex with…

OPTIMIZING PrEP CASCADE OUTCOMES FOR SEXUAL HEALTH CLINIC NAVIGATION

Sexual Health and STI clinics are increasingly integrating PrEP navigation services to identify, refer and link eligible patients to PrEP. Increasing the effectiveness of these programs requires optimizing each step of the PrEP cascade, i.e., acceptance of navigation and referral, PrEP initiation, and sustained PrEP use. Epidemiological data have focused almost exclusively on demographic predictors…